APA (7th ed.) Citation

Wang, Y., Liang, Y., Luo, D., Ye, F., Jin, Y., Wang, L., . . . Yang, Q. (2025). EDEM1 Inhibits Endoplasmic Reticulum Stress to Induce Doxorubicin Resistance through Accelerating ERAD and Activating Keap1/Nrf2 Antioxidant Pathway in Triple-Negative Breast Cancer. American Association for the Advancement of Science (AAAS).

Chicago Style (17th ed.) Citation

Wang, Yajie, et al. EDEM1 Inhibits Endoplasmic Reticulum Stress to Induce Doxorubicin Resistance Through Accelerating ERAD and Activating Keap1/Nrf2 Antioxidant Pathway in Triple-Negative Breast Cancer. American Association for the Advancement of Science (AAAS), 2025.

MLA (9th ed.) Citation

Wang, Yajie, et al. EDEM1 Inhibits Endoplasmic Reticulum Stress to Induce Doxorubicin Resistance Through Accelerating ERAD and Activating Keap1/Nrf2 Antioxidant Pathway in Triple-Negative Breast Cancer. American Association for the Advancement of Science (AAAS), 2025.